Recurrent Anaplastic Large Cell Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB02379Beta-D-Glucose1Completed1
DB00958Carboplatin1Completed1
DB14707Cemiplimab1Recruiting1
DB00531Cyclophosphamide1Completed1
DB00531Cyclophosphamide1Recruiting1
DB00773Etoposide1Completed1
DB14999Human interferon beta1Recruiting1
DB01181Ifosfamide1Completed1
DB14867Parsaclisib1Recruiting1
DB06176Romidepsin1Completed1
DB06176Romidepsin1Recruiting1
DB11119Sodium iodide1Recruiting1
DB17404AFM-131 / 2Active Not Recruiting1
DB18674Acimtamig1 / 2Active Not Recruiting1
DB02379Beta-D-Glucose1 / 2Completed1
DB00262Carmustine1 / 2Completed1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB00987Cytarabine1 / 2Completed1
DB00773Etoposide1 / 2Completed1
DB01073Fludarabine1 / 2Active Not Recruiting1
DB00480Lenalidomide1 / 2Completed1
DB00888Mechlorethamine1 / 2Completed1
DB09037Pembrolizumab1 / 2Active Not Recruiting2
DB06813Pralatrexate1 / 2Active Not Recruiting1
DB00073Rituximab1 / 2Completed1
DB06176Romidepsin1 / 2Active Not Recruiting1
DB00531Cyclophosphamide2Terminated1
DB00099Filgrastim2Terminated1
DB01073Fludarabine2Terminated1
DB00688Mycophenolate mofetil2Terminated1
DB06132Nivolumab2Terminated1
DB09035Nivolumab2Terminated1
DB06306Onalespib2Terminated1
DB00864Tacrolimus2Terminated1